Sign In
Buy OCUL
$8.35
+0.0400 (+0.481%)
At Close: Jun 03, 2026
Ocular Therapeutix™ to Hold Virtual 2020 Annual Meeting Of Stockholders
12:00am, Monday, 15'th Jun 2020
Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative thera
Is There An Opportunity With Ocular Therapeutix, Inc.'s (NASDAQ:OCUL) 46% Undervaluation?
10:13am, Friday, 12'th Jun 2020
In this article we are going to estimate the intrinsic value of Ocular Therapeutix, Inc. (NASDAQ:OCUL) by taking the...
Cyber Threat Intelligence (CTI) in a Nutshell — 2
12:25pm, Thursday, 11'th Jun 2020
Understanding Threats and Intrusions
Ocular Therapeutix™ to Present at the 2020 Raymond James Human Health Innovation Conference
12:00pm, Wednesday, 10'th Jun 2020
Ocular Therapeutix, Inc. (NASDAQ:OCUL) a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today
Jun 08, 2020 (The Expresswire) --
"Final Report will add the analysis of the impact of COVID-19 on this industry." Global “Tyrosine Kinase Inhibitor Market”...
Ocular Therapeutix™ to Present at the Jefferies Virtual Healthcare Conference
12:00pm, Friday, 29'th May 2020
Ocular Therapeutix, Inc. (NASDAQ:OCUL) a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today
Ocular Therapeutix™ to Present at the Jefferies Virtual Healthcare Conference
12:00am, Friday, 29'th May 2020
Ocular Therapeutix, Inc. (NASDAQ:OCUL) a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therap
Small Drug Industry Prospects Bright Amid Coronavirus Gloom
01:40pm, Wednesday, 27'th May 2020
Small Drug Industry Prospects Bright Amid Coronavirus Gloom
7 “Perfect 10” Stocks to Buy Now
02:00pm, Monday, 25'th May 2020
In a financial environment riddled with unprecedented levels of uncertainty, investors are at wits’ end. When it comes to finding an investment strategy that will yield returns, traditional methods
Why Ocular Therapeutix Skyrocketed 19.3% Today
08:19pm, Friday, 22'nd May 2020
A public share offering that's closing today and will add $45 million, before fees, to its balance sheet is sending shares of Ocular Therapeutix (NASDAQ: OCUL) soaring 19.3% at 3:47 p.m. EST on Frida
